Gilead Sciences GILD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.02B-7.4% | $2.18B-28.5% | $3.05B+55.7% | $1.96B+49.0% | $1.32B-26.2% | ||
| $218M-5.2% | $230M0.0% | $230M+2.2% | $225M+7.7% | $209M-5.9% | ||
| $2.54B-23.5% | $3.33B-19.0% | $4.11B+397% | $827M-52.9% | $1.76B-40.9% | ||
| $117M-42.9% | $205M+39.5% | $147M+37.4% | $107M+2.9% | $104M-29.3% | ||
| $109M-82.1% | $609M+265% | $167M+695% | $21M-92.3% | $273M+264% | ||
| $1.77B+196% | -$1.84B-330% | -$427M+79.8% | -$2.12B-410% | -$415M-84.4% | ||
| $1.04B+4.6% | $994M-1.1% | $1.01B+1.1% | $994M-1.6% | $1.01B+3.8% | ||
| $419M+82.2% | $230M-47.1% | $435M-17.5% | $527M-27.8% | $730M+109% | ||
| -$4.24B-236% | -$1.26B+15.2% | -$1.49B+5.0% | -$1.57B+54.3% | -$3.43B— | ||
| $65M— | —— | —— | -$2.78B-34.8% | -$2.07B-142% | ||
| $2.43B-22.3% | $3.12B-21.2% | $3.96B+450% | $720M-56.4% | $1.65B-41.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gilead Sciences generate?
- Gilead Sciences (GILD) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Gilead Sciences's free cash flow?
- After $576.0M of capital expenditures, Gilead Sciences's free cash flow was $10.2B over the trailing twelve months, up 3.9% year over year.
- Where does Gilead Sciences's cash flow data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
